The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old down syndrome children: A randomized clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3304-3311

  Van Trotsenburg, A S Paul ^a   Vulsma, Thomas ^a   Rutgers Van Rozenburg Marres, Susanne L ^a   Van Baar, Anneloes L ^b   Ridder, Jeannette C D ^a   Heymans, Hugo S A ^a   Tijssen, Jan G P ^a   De Vijlder, Jan J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THYROTROPIN; THYROXINE;

ARTICLE; BODY GROWTH; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOUBLE BLIND PROCEDURE; DOWN SYNDROME; DRUG EFFECT; HUMAN; HYPOTHYROIDISM; INFANT; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; MOTOR DEVELOPMENT; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; APGAR SCORE; CHILD DEVELOPMENT; FEMALE; GESTATIONAL AGE; GROWTH; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID FUNCTION TEST;

APGAR SCORE; CHILD DEVELOPMENT; DOUBLE-BLIND METHOD; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; GROWTH; HUMANS; INFANT, NEWBORN; MALE; THYROID FUNCTION TESTS; THYROXINE;

EID: 21244449614     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0130     Document Type: Article

References (32)

1. Klein RZ, Mitchell ML 2000 Hypothyroidism in infants and children. Neonatal screening. In: Braverman LE, Utiger RD, eds. Werner, Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 973-988
2. Derksen-Lubsen G, Verkerk PH 1996 Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature data. Pediatr Res 39:561-566
3. Daliva AL, Linder B, DiMartino-Nardi J, Saenger P 2000 Three-year follow-up of borderline congenital hypothyroidism. J Pediatr 136:53-56
4. Kohler B, Schnabel D, Biebermann H, Gruters A 1996 Transient congenital hypothyroidism and hyperthyrotropinemia: normal thyroid function and physical development at the ages of 6-14 years. J Clin Endocrinol Metab 81:1563-1567
5. Rapaport R 2000 Congenital hypothyroidism: expanding the spectrum. J Pediatr 136:10-12
6. Sharav T, Collins Jr RM, Baab PJ 1988 Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin. Am J Dis Child 142:1302-1306
7. Toledo C, Alembik Y, Dott B, Finck S, Stoll C 1997 Anomalies du fonctionnement thyroidien des enfants trisomiques 21: Anomalies of thyroid function in children with Down syndrome. Arch Pediat 4:116-120
8. Jimenez-Lopez V, Arias A, Arata-Bellabarba G, Vivas E, Delgado MC, Paoli M 2001 Concentration of thyrotropic hormone and free thyroxin in children with Down's syndrome. Invest Clin 42:123-130
9. Rubello D, Pozzan GB, Casara D, Girelli ME, Boccato S, Rigon F, Baccichetti C, Piccolo M, Betterle C, Busnardo B 1995 Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 18:35-40
10. Crino A, Ciampalini P, DiGilio MC, Obregon MG, Giannotti A, Borrelli P 1993 Abnormal thyrotropin secretion in Down's syndrome. In: Castells S, Wisniewski KE, eds. Growth hormone treatment in Down's syndrome. New York: John Wiley and Sons; 101-109
11. van Trotsenburg ASP, Vulsma T, van Santen HM, Cheung W, de Vijlder JJM 2003 Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 88:1512-1515
12. Epstein CJ 2001 Down syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 1223- 1256
13. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM 2000 Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 47:316-323
14. Bayley N 1993 Bayley Scales of Infant Development: manual. 2nd ed. San Antonio, TX: Psychological Corp.
15. Schneider MJ, Cools GMP, Reuter J 1990 KID-N. Kent Infant Development Scale Nederlandse bewerking. Lisse, The Netherlands: Swets and Zeitlinger
16. Pocock SJ 1988 Clinical trials: a practical approach. Chichester, UK: John Wiley and Sons; 123-138
17. Brent GA, Larsen P Reed 2000 Treatment of hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner, Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 853-858
18. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549-555
19. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, Vulsma T, Wiersinga WM, Drexhage HA, Vader HL 1999 Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 50:149-155
20. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ 2003 Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 59:282-288
21. Pueschel SM, Pezzullo JC 1985 Thyroid dysfunction in Down syndrome. Am J Dis Child 139:636-639
22. Selikowitz M 1993 A five-year longitudinal study of thyroid function in children with Down syndrome. Dev Med Child Neurol 35:396-401
23. Koch R, Share J, Graliker B 1965 The effects of cytomel on young children with Down's syndrome (mongolism): a double-blind longitudinal study. J Pediatr 66:776-778
24. Tirosh E, Taub Y, Scher A, Jaffe M, Hochberg Z 1989 Short-term efficacy of thyroid hormone supplementation for patients with Down syndrome and low-borderline thyroid function. Am J Ment Retard 93:652-656
25. Sharav T 1993 Thyroid dysfunction and growth retardation in Down's syndrome. In: Castells S, Wisniewski KE, eds. Growth hormone treatment in Down's syndrome. New York: John Wiley and Sons; 73-91
26. Fisher DA, Schoen EJ, La Franchi S, Mandel SH, Nelson JC, Carlton EI, Goshi JH 2000 The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J Clin Endocrinol Metab 85:2722-2727
27. Van Vliet G 2001 Treatment of congenital hypothyroidism. Lancet 358:86-87
28. Rovet JF 2002 Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Neuropsychol Dev Cogn Sect C Child Neuropsychol 8:150-162
29. Simons WF, Fuggle PW, Grant DB, Smith I 1994 Intellectual development at 10 years in early treated congenital hypothyroidism. Arch Dis Child 71:232-234
30. Oerbeck B, Sundet K, Kase BF, Heyerdahl S 2003 Congenital hypothyroidism: influence of disease severity and l-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 112:923-930
31. Heyerdahl S, Oerbeck B 2003 Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid 13:1029-1038
32. Simoneau-Roy J, Marti S, Deal C, Huot C, Robaey P, Van Vliet G 2004 Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 144:747-752